Invention Grant
- Patent Title: FXIII detection for verifying serum sample and sample size and for detecting dilution
-
Application No.: US10966650Application Date: 2004-10-14
-
Publication No.: US07141362B2Publication Date: 2006-11-28
- Inventor: Steven R. Binder , Jodi L. Goodrich , Zara Safarian
- Applicant: Steven R. Binder , Jodi L. Goodrich , Zara Safarian
- Applicant Address: US CA Hercules
- Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee Address: US CA Hercules
- Agency: Townsend and Townsend and Crew, LLP
- Agent M. Henry Heines
- Main IPC: G01N33/53
- IPC: G01N33/53

Abstract:
Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.
Public/Granted literature
- US20050106640A1 FXIII detection for verifying serum sample and sample size and for detecting dilution Public/Granted day:2005-05-19
Information query
IPC分类: